Loading organizations...
Banyan Pacific Capital operates as an investment firm, deploying capital into technology and life science companies at various growth stages. The firm invests from seed to pre-IPO rounds, utilizing strategic funds to back innovation. It executes a global deployment strategy, leveraging insights from Chinese and North American markets to nurture promising ventures.
Established in 2015, Banyan Pacific Capital began operations to capitalize on evolving sectors. Susu Liu and Jiajun Shao are key figures, guiding its strategic direction. The firm’s origin stems from a recognized need for specialized capital to fuel international advancements in technology and life sciences.
Banyan Pacific Capital primarily serves technology and life science companies, offering financial backing and strategic partnership. Its guiding principles prioritize partners, foster collaborative growth, and aim for societal contribution through its portfolio. The firm envisions continued international expansion and generating future value within its high-growth investment areas.
Banyan Pacific Capital has 4 tracked investments across 4 companies. The latest tracked deal is $9.9M Pre-Series A in Waysia in September 2022.